Drugs / Autologous dendritic cells transduced with Ad encoding NS3
Autologous dendritic cells transduced with Ad encoding NS3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02309086 | May 2011 → May 2013 | chronic hepatitis C virus infection | Clinica Universidad de Navarra, Universidad de Navarra | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous dendritic cells transduced with Ad encoding NS3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02309086 ↗ |
| Modality | Cell therapy | “Autologous dendritic cells transduced with Ad encoding NS3” NCT02309086 ↗ |
| Route | Subcutaneous | “via subcutaneous injection” NCT02309086 ↗ |